Cases & Deals

Cardinal Health acquires The Harvard Drug Group for $1.115 billion

Clients Cardinal Health, Inc.

Jones Day advised Cardinal Health in its acquisition of The Harvard Drug Group, a distributor of generic pharmaceuticals, over-the-counter medications, and related products to retail, institutional, and alternate care customers from Court Square Capital Partners for $1.115 billion.

In addition to M&A representation, Jones Day provided health care, employee benefits, intellectual property, and antitrust advice regarding this transaction.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.